(Q34652351)

3 August 2017

title

Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects (English)

1 reference

3 August 2017

0 references

1

0 references

Frank L Greenway

2

object named as

Frank L Greenway

1 reference

3 August 2017

Walter Ling

3

1 reference

3 August 2017

Lisa Pedicone

4

1 reference

3 August 2017

Jean Lachowicz

5

1 reference

3 August 2017

Catherine D Strader

6

1 reference

3 August 2017

Rudolf Kwan

7

1 reference

3 August 2017

Ecopipam Obesity Study Group

8

1 reference

3 August 2017

language of work or name

1 reference

1 July 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

15

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

1717-1731

1 reference

Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Prevalence of obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

The continuing epidemics of obesity and diabetes in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Prevalence of obesity in Uruguay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Prevalence of obesity in Iran.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Body mass index and the prevalence of hypertension and dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Obesity and the Risk of New-Onset Atrial Fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Dopamine receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Pharmacology of flavor preference conditioning in sham-feeding rats: effects of dopamine receptor antagonists.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Depression in association with severe obesity: changes with weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Psychosocial aspects of obesity and obesity surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

A health status assessment of the impact of weight loss following Roux-en-Y gastric bypass for clinically severe obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Brain monoamine receptors in a chronic unpredictable stress model in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.205

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.205

1 reference

3 August 2017

1 reference